The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Gene therapy targeting survivin selectively induces pulmonary vascular apoptosis and reverses pulmonary arterial hypertension
Open accessAbstract
Pulmonary arterial hypertension (PAH) is characterized by genetic and acquired abnormalities that suppress apoptosis and enhance cell proliferation in the vascular wall, including downregulation of the bone morphogenetic protein axis and voltage-gated K+ (Kv) channels. Survivin is an "inhibitor of apoptosis" protein, previously thought to be expressed primarily in cancer cells. We found that survivin was expressed in the pulmonary arteries (PAs) of 6 patients with PAH and rats with monocrotaline-induced PAH, but not in the PAs of 3 patients and rats without PAH. Gene therapy with inhalation of an adenovirus carrying a phosphorylation-deficient survivin mutant with dominant-negative properties reversed established monocrotaline-induced PAH and prolonged survival by 25%. The survivin mutant lowered pulmonary vascular resistance, RV hypertrophy, and PA medial hypertrophy. Both in vitro and in vivo, inhibition of survivin induced PA smooth muscle cell apoptosis, decreased proliferation, depolarized mitochondria, caused efflux of cytochrome c in the cytoplasm and translocation of apoptosis-inducing factor into the nucleus, and increased Kv channel current; the opposite effects were observed with gene transfer of WT survivin, both in vivo and in vitro. Inhibition of the inappropriate expression of survivin that accompanies human and experimental PAH is a novel therapeutic strategy that acts by inducing vascular mitochondria-dependent apoptosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Calcium's Role in Mechanotransduction during Muscle Development
Benavides Damm, T., & Egli, M. (2014) · Cellular Physiology and Biochemistry · doi:10.1159/000356667 · Cited by 14,502
IAP proteins: blocking the road to death's door
Salvesen, G. S., & Duckett, C. S. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm830 · Cited by 1,756
The Effect of High Doses of Calcium-Channel Blockers on Survival in Primary Pulmonary Hypertension
Rich, S., Kaufmann, E., & Levy, P. S. (1992) · New England Journal of Medicine · doi:10.1056/nejm199207093270203 · Cited by 1,550
Lane, K. B., Machado, R. D., Pauciulo, M. W., Thomson, J. R., Phillips, J. A., Loyd, J. E., Nichols, W. C., & Trembath, R. C. (2000) · Nature Genetics · doi:10.1038/79226 · Cited by 1,495
Validating survivin as a cancer therapeutic target
Altieri, D. C. (2003) · Nature Reviews Cancer · doi:10.1038/nrc968 · Cited by 1,206
Endothelial Dysfunction in Pulmonary Hypertension
Budhiraja, R., Tuder, R. M., & Hassoun, P. M. (2004) · Circulation · doi:10.1161/01.cir.0000102381.57477.50 · Cited by 768
Thomson, J. R., Machado, R. D., Pauciulo, M. W., Morgan, N. V., Humbert, M., Elliott, G. C., Ward, K., Yacoub, M., Mikhail, G., Rogers, P., et al. (2000) · Journal of Medical Genetics · doi:10.1136/jmg.37.10.741 · Cited by 732
Regulation of apoptosis at cell division by p34 cdc2 phosphorylation of survivin
O'Connor, D. S., Grossman, D., Plescia, J., Li, F., Zhang, H., Villa, A., Tognin, S., Marchisio, P. C., & Altieri, D. C. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.240390697 · Cited by 611
Duchen, M. R. (1999) · The Journal of Physiology · doi:10.1111/j.1469-7793.1999.001aa.x · Cited by 610
Apoptosis‐inducing factor (AIF): a ubiquitous mitochondrial oxidoreductase involved in apoptosis
Daugas, E., Nochy, D., Ravagnan, L., Loeffler, M., Susin, S. A., Zamzami, N., & Kroemer, G. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01731-2 · Cited by 466
The mechanism of acute hypoxic pulmonary vasoconstriction: the tale of two channels
Weir, E. K., & Archer, S. L. (1995) · The FASEB Journal · doi:10.1096/fasebj.9.2.7781921 · Cited by 465
McMurtry, M. S., Bonnet, S., Wu, X., Dyck, J. R. B., Haromy, A., Hashimoto, K., & Michelakis, E. D. (2004) · Circulation Research · doi:10.1161/01.res.0000145360.16770.9f · Cited by 453
Self-citationMorrell, N. W., Yang, X., Upton, P. D., Jourdan, K. B., Morgan, N., Sheares, K. K., & Trembath, R. C. (2001) · Circulation · doi:10.1161/hc3201.094152 · Cited by 453
Yu, Y., Fantozzi, I., Remillard, C. V., Landsberg, J. W., Kunichika, N., Platoshyn, O., Tigno, D. D., Thistlethwaite, P. A., Rubin, L. J., & Yuan, J. X.-J. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405908101 · Cited by 430
Yuan, J. X.-J., Aldinger, A. M., Juhaszova, M., Wang, J., Conte, J. V., Gaine, S. P., Orens, J. B., & Rubin, L. J. (1998) · Circulation · doi:10.1161/01.cir.98.14.1400 · Cited by 425
Archer, S. L., Souil, E., Dinh-Xuan, A. T., Schremmer, B., Mercier, J. C., El Yaagoubi, A., Nguyen-Huu, L., Reeve, H. L., & Hampl, V (1998) · Journal of Clinical Investigation · doi:10.1172/jci333 · Cited by 410
Mitochondrial survivin inhibits apoptosis and promotes tumorigenesis
Dohi, T., Beltrami, E., Wall, N. R., Plescia, J., & Altieri, D. C. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200422222 · Cited by 405
Abe, K., Shimokawa, H., Morikawa, K., Uwatoku, T., Oi, K., Matsumoto, Y., Hattori, T., Nakashima, Y., Kaibuchi, K., Sueishi, K., et al. (2004) · Circulation Research · doi:10.1161/01.res.0000111804.34509.94 · Cited by 402
Complete reversal of fatal pulmonary hypertension in rats by a serine elastase inhibitor
Cowan, K. N., Heilbut, A., Humpl, T., Lam, C., Ito, S., & Rabinovitch, M. (2000) · Nature Medicine · doi:10.1038/76282 · Cited by 378
Michelakis, E. D., McMurtry, M. S., Wu, X.-C., Dyck, J. R. B., Moudgil, R., Hopkins, T. A., Lopaschuk, G. D., Puttagunta, L., Waite, R., & Archer, S. L. (2002) · Circulation · doi:10.1161/hc0202.101974 · Cited by 369
Self-citationPrimary Pulmonary Hypertension: A Vascular Biology and Translational Research “Work in Progress”
Archer, S., & Rich, S. (2000) · Circulation · doi:10.1161/01.cir.102.22.2781 · Cited by 354
Diversity in Mitochondrial Function Explains Differences in Vascular Oxygen Sensing
Michelakis, E. D., Hampl, V., Nsair, A., Wu, X., Harry, G., Haromy, A., Gurtu, R., & Archer, S. L. (2002) · Circulation Research · doi:10.1161/01.res.0000024689.07590.c2 · Cited by 309 · cited 3×
“Measurement of the mitochondrial membrane potential in live PASMCs was performed using TMRM, as previously described (20, 26).”
Mitochondria and Ca2+in cell physiology and pathophysiology
Duchen, M. R. (2000) · Cell Calcium · doi:10.1054/ceca.2000.0170 · Cited by 309
Attenuated K+ channel gene transcription in primary pulmonary hypertension
Yuan, X.-J., Wang, J., Juhaszova, M., Gaine, S. P., & Rubin, L. J. (1998) · The Lancet · doi:10.1016/s0140-6736(05)78495-6 · Cited by 298
Geraci, M. W., Moore, M., Gesell, T., Yeager, M. E., Alger, L., Golpon, H., Gao, B., Loyd, J. E., Tuder, R. M., & Voelkel, N. F. (2001) · Circulation Research · doi:10.1161/01.res.88.6.555 · Cited by 267
Pozeg, Z. I., Michelakis, E. D., McMurtry, M. S., Thébaud, B., Wu, X.-C., Dyck, J. R. B., Hashimoto, K., Wang, S., Moudgil, R., Harry, G., et al. (2003) · Circulation · doi:10.1161/01.cir.0000062688.76508.b3 · Cited by 260
Self-citationHydrogen peroxide elicits pulmonary arterial relaxation and guanylate cyclase activation
Burke, T. M., & Wolin, M. S. (1987) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1987.252.4.h721 · Cited by 255
Nishimura, T., Vaszar, L. T., Faul, J. L., Zhao, G., Berry, G. J., Shi, L., Qiu, D., Benson, G., Pearl, R. G., & Kao, P. N. (2003) · Circulation · doi:10.1161/01.cir.0000087592.47401.37 · Cited by 251
Activation of K+channels: an essential pathway in programmed cell death
Remillard, C. V., & Yuan, J. X.-J. (2004) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00041.2003 · Cited by 251
(2002) · PubMed · Cited by 228
Primary Pulmonary Hypertension Between Inflammation and Cancer
Voelkel, N. F., Cool, C., Lee, S. D., Wright, L., Geraci, M. W., & Tuder, R. M. (1998) · Chest · doi:10.1378/chest.114.3_supplement.225s · Cited by 221
Protective Role of Angiopoietin-1 in Experimental Pulmonary Hypertension
Zhao, Y. D., Campbell, A. I. M., Robb, M., Ng, D., & Stewart, D. J. (2003) · Circulation Research · doi:10.1161/01.res.0000070587.79937.f0 · Cited by 176
Michelakis, E. D., Rebeyka, I., Wu, X., Nsair, A., Thébaud, B., Hashimoto, K., Dyck, J. R. B., Haromy, A., Harry, G., Barr, A., et al. (2002) · Circulation Research · doi:10.1161/01.res.0000035057.63303.d1 · Cited by 167
Sustained membrane depolarization and pulmonary artery smooth muscle cell proliferation
Platoshyn, O., Golovina, V. A., Bailey, C. L., Limsuwan, A., Krick, S., Juhaszova, M., Seiden, J. E., Rubin, L. J., & Yuan, J. X.-J. (2000) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.2000.279.5.c1540 · Cited by 164
Inhibitor of apoptosis protein survivin regulates vascular injury
Blanc‐Brude, O., Yu, J., Simosa, H. F., Conte, M. S., Sessa, W. C., & Altieri, D. C. (2002) · Nature Medicine · doi:10.1038/nm750 · Cited by 148
Serial noninvasive assessment of progressive pulmonary hypertension in a rat model
Jones, J. E., Mendes, L. A., Rudd, M. A., Russo, G., Loscalzo, J., & Zhang, Y. (2002) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00979.2001 · Cited by 147
Arcot, S. S., Lipke, D. W., Gillespie, M. N., & Olson, J. W. (1993) · Biochemical Pharmacology · doi:10.1016/0006-2952(93)90675-m · Cited by 93
Cytochrome c activates K+ channels before inducing apoptosis
Platoshyn, O., Zhang, S., McDaniel, S. S., & Yuan, J. X. ‐. (2002) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00592.2001 · Cited by 81
Therapy of Pulmonary Hypertension: The Evolution from Vasodilators to Antiproliferative Agents
Rubin, L. J. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2208008 · Cited by 67
Hydrogen peroxide modulates the Kv1.5 channel expressed in a mammalian cell line
Caouette, D., Dongmo, C., B�rub�, J., Fournier, D., & Daleau, P. (2003) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-003-0834-0 · Cited by 51
Cited by
Bonnet, S., Archer, S. L., Allalunis-Turner, J., Haromy, A., Beaulieu, C., Thompson, R., Lee, C. T., Lopaschuk, G. D., Puttagunta, L., Bonnet, S., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2006.10.020 · Cited by 1,530
Molecular pathogenesis of pulmonary arterial hypertension
Rabinovitch, M. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33452 · Cited by 880
Cellular and Molecular Basis of Pulmonary Arterial Hypertension
Morrell, N. W., Adnot, S., Archer, S. L., Dupuis, J., Lloyd Jones, P., MacLean, M. R., McMurtry, I. F., Stenmark, K. R., Thistlethwaite, P. A., Weissmann, N., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.04.018 · Cited by 819
Stenmark, K. R., Meyrick, B., Galie, N., Mooi, W. J., & McMurtry, I. F. (2009) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00217.2009 · Cited by 774
Inflammation, Growth Factors, and Pulmonary Vascular Remodeling
Hassoun, P. M., Mouthon, L., Barberà, J. A., Eddahibi, S., Flores, S. C., Grimminger, F., Jones, P. L., Maitland, M. L., Michelakis, E. D., Morrell, N. W., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.04.006 · Cited by 710
Metadata
- Authors
- McMurtry, M. S.
- Venue
- Journal of Clinical Investigation
- Published
- 2005-06-01
- Volume
- 115
- Issue
- 6
- Pages
- 1479-1491
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2128937433
- Cited by
- 368
- References
- 40
- FWCI
- 18.25
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.